Wellesley, MA (PRWEB) October 30, 2013
According to a new technical market research report, Global Biochip Markets: Microarrays and Lab-on-a-Chip from BCC Research (http://www.bccresearch.com), the global market for biochips was valued at $3.3 billion in 2012 and is expected to increase to nearly $3.9 billion in 2013. BCC Research projects the market to reach $14.4 billion in 2018, and register a compound annual growth rate (CAGR) of 30% for the period 2013 to 2018.
Biochip-based products have game-changing potential across a range of markets. Growth in next-generation sequencing-based diagnostics applications, use of lab-on-a-chip (LOAC) formats in point of care applications, and migration toward more integrated on-chip systems will impact everything from drug development to diagnostics.
With the discovery of new, clinically relevant genomic and proteomic content, biochips are poised to meet the need for new-generation diagnostics that can measure multiple biomarkers in a single assay. A shift in focus from R&D-related tools to clinical applications that are accurate, easy to use, low cost, and suitable for automation will drive tremendous growth in this market over the next five years.
This report from BCC Research provides a study of the main biochip products that are used in the five end-user segments: research tools, drug discovery and development, diagnostics, sequencing, and applied markets. The report discusses the driving forces in the market, product types, key market applications, companies and alliances, industry dynamics, patents, future market potential, and product sales forecasts for the year 2013 and 2018. In addition, the geographical market
Copyright©2012 Vocus, Inc.
All rights reserved